Ann: Lupin Modification Trial Validates Manufacturing Scale Up, page-2

Great news.

Highlights:  Wide Open Agriculture successfully completed a manufacturing trial of its BP80F lupin protein production process, demonstrating a substantial leap in eA cienc.
 The eA ciencygains achieved in the trial show the potential for WOA’s technology to scale eAectivelyand at lower cost than previously anticipated.
 Trial achieved up to 80% reduction in energy consumption and ~50% reduction in processing time for WOA’s licensed IP step, while maintaining product quality.
 The trial was conducted in the U.S.A. and used commercial-scale, automated equipment not previously applied to lupin protein.
 Enhances protection of WOA’s proprietary technology by using an automated “black box” configuration.
 Outcome of the trial has shown that improvements in Operating Expenditure (Opex) and Capital Expenditure (Capex) can be achieved both in WOA’s German facility and for future commercial scale facilities.